Evidence map›Paper›PMID 36158913›Full record

ReviewWorld journal of hepatology2022

Alfapump

Delphine Weil-Verhoeven, Vincent Di Martino, Guido Stirnimann, Jean Paul Cervoni, Eric Nguyen-Khac, Thierry Thévenot

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Drainage of ascites in cirrhosis.World journal of hepatology · 2024
    Review
  4. Palliative long-term abdominal drainsWorld journal of hepatology · 2024
    Article
  5. Innovative approaches to the management of ascites in cirrhosis.JHEP reports : innovation in hepatology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Delphine Weil-VerhoevenService d'Hépatologie Et Soins Intensifs Digestifs, CHRU Jean Minjoz, Besançon 25030, France.
Vincent Di MartinoService d'Hépatologie Et Soins Intensifs Digestifs, CHRU Jean Minjoz, Besançon 25030, France.
Guido StirnimannDepartment of Visceral Surgery and Medicine, Inselspital University Hospital and University of Bern, Bern 3010, Switzerland.
Jean Paul CervoniService d'Hépatologie Et Soins Intensifs Digestifs, CHRU Jean Minjoz, Besançon 25030, France.
Eric Nguyen-KhacService d'Hépato-Gastroentérologie, CHU Amiens-Picardie, Amiens 80080, France.
Thierry ThévenotService d'Hépatologie Et Soins Intensifs Digestifs, CHRU Jean Minjoz, Besançon 25030, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Refractory ascites (RA) is a frequent and life-threatening complication of cirrhosis. In selected patients with RA, transjugular intrahepatic portosystemic shunt (TIPS) placement and liver transplantation (LT) are currently considered the best therapeutic alternatives to repeated large volume paracentesis. In patients with a contraindication to TIPS or LT, the alfapump

Indexed as

AlfapumpAutomated low flow ascites pumpCirrhosisLiverRefractory ascites

Identifiers

PMID36158913
PMCPMC9376776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.